Table 4 Pharmacokinetics parameters following intranasal administration of AmyP53 in rats.

From: Preclinical assessment of a ganglioside-targeted therapy for Parkinson’s disease with the first-in-class adaptive peptide AmyP53

Parameter

Value in brain tissue

Cmax (ng/mL)

1766

Tmax (min)

5

AUC 0→120 (ng.mL/min)

62794

T1/2

61

  1. Retrieved from ref47. (published by MDPI under the terms and conditions of the Creative Commons Attribution (CC BY) license).
Back to article page